SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-21-000161
Filing Date
2021-07-28
Accepted
2021-07-28 10:52:40
Documents
13
Period of Report
2021-07-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20210728.htm   iXBRL 8-K 50252
2 EX-99.1 a8-k_28july2021xexhibit991.htm EX-99.1 54395
  Complete submission text file 0001651308-21-000161.txt   254931

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20210728.xsd EX-101.SCH 1996
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20210728_lab.xml EX-101.LAB 25214
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20210728_pre.xml EX-101.PRE 13249
6 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20210728_htm.xml XML 11485
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 211120668
SIC: 2834 Pharmaceutical Preparations